TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%

Država: Kanada

Jezik: engleski

Izvor: Health Canada

Aktivni sastojci:

CLOBETASOL PROPIONATE

Dostupno od:

TARO PHARMACEUTICALS INC

ATC koda:

D07AD01

INN (International ime):

CLOBETASOL

Doziranje:

0.05%

Farmaceutski oblik:

SOLUTION

Sastav:

CLOBETASOL PROPIONATE 0.05%

Administracija rute:

TOPICAL

Jedinice u paketu:

60 ML

Tip recepta:

Prescription

Područje terapije:

ANTI-INFLAMMATORY AGENTS

Proizvod sažetak:

Active ingredient group (AIG) number: 0110995001; AHFS:

Status autorizacije:

APPROVED

Datum autorizacije:

2005-09-20

Svojstava lijeka

Prescribing Information
Taro-Clobetasol
Pr
Clobetasol Propionate Topical Solution USP, 0,05% w/w
Therapeutic Classification
Topical corticosteroid
Taro Pharmaceuticals Inc.
Date of Preparation:
130 East Drive
September 22, 2005
Brampton, Ontario
L6T 1C1
Control # 101189
Taro Pharmaceuticals Inc.
1
2002.4.16
Prescribing Information
Pr
Clobetasol Propionate Topical Solution USP, 0.05% w/w
(In an aqueous-alcohol base)
Topical Corticosteroid
Clinical Pharmacology
The corticosteroids are a class of compounds comprising steroid
hormones
secreted by the adrenal cortex and their synthetic analogs. In
pharmacologic
doses, corticosteroids are used primarily for their anti-inflammatory
and/or
immunosuppressive effects. Topical corticosteroids such as clobetasol
propionate are effective in the treatment of corticosteroid-responsive
dermatoses
primarily because of their anti-inflammatory, anti-pruritic, and
vasoconstrictive
actions. However, while the physiologic, pharmacologic and clinical
effects of the
corticosteroids are well known, the exact mechanisms of their actions
in each
disease are uncertain.
Clobetasol propionate has been shown to have topical and systemic
pharmacologic and metabolic effects characteristic of the
corticosteroid class of
drugs.
Indications and Clinical Use
Clobetasol Propionate Topical Solution is indicated in the topical
therapy of
recalcitrant corticosteroid-responsive dermatoses of the scalp,
including
Taro Pharmaceuticals Inc.
2
2002.4.16
recalcitrant cases of psoriasis and seborrheic dermatitis.
Contraindications
Clobetasol Propionate Topical Solution is not indicated in the
treatment of
infected lesions of the skin if no anti-infective agent is used
simultaneously,
fungal and viral infections of the scalp (including herpes simplex,
vaccinia and
varicella) and tuberculous lesions of the skin. Clobetasol Propionate
Topical
Solution is also contraindicated in patients who are hypersensitive to
any of the
components of the preparation. Clobestasol propionate is also
contraindicated in
dermatoses